SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Foster Eric)
 

Sökning: WFRF:(Foster Eric) > Phase 3 trial of hu...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00006131naa a2200685 4500
001oai:DiVA.org:uu-450607
003SwePub
008210817s2021 | |||||||||||000 ||eng|
024a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4506072 URI
024a https://doi.org/10.1111/ajt.161742 DOI
040 a (SwePub)uu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Markmann, James F.u Harvard Med Sch, Div Transplant Surg, Massachusetts Gen Hosp, Boston, MA 02115 USA.4 aut
2451 0a Phase 3 trial of human islet-after-kidney transplantation in type 1 diabetes
264 1b John Wiley & Sons,c 2021
338 a print2 rdacarrier
520 a Allogeneic islet transplant offers a minimally invasive option for beta cell replacement in the treatment of type 1 diabetes (T1D). The CIT consortium trial of purified human pancreatic islets (PHPI) in patients with T1D after kidney transplant (CIT06), a National Institutes of Health-sponsored phase 3, prospective, open-label, single-arm pivotal trial of PHPI, was conducted in 24 patients with impaired awareness of hypoglycemia while receiving intensive insulin therapy. PHPI were manufactured using standardized processes. PHPI transplantation was effective with 62.5% of patients achieving the primary endpoint of freedom from severe hypoglycemic events and HbA(1c) <= 6.5% or reduced by >= 1 percentage point at 1 year posttransplant. Median HbA(1c)declined from 8.1% before to 6.0% at 1 year and 6.3% at 2 and 3 years following transplant (P < .001 for all vs baseline), with related improvements in hypoglycemia awareness and glucose variability. The improved metabolic control was associated with better health-related and diabetes-related quality of life. The procedure was safe and kidney allograft function remained stable after 3 years. These results add to evidence establishing allogeneic islet transplant as a safe and effective treatment for patients with T1D and unstable glucose control despite intensive insulin treatment, supporting the indication for PHPI in the post-renal transplant setting.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Endokrinologi och diabetes0 (SwePub)302052 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Endocrinology and Diabetes0 (SwePub)302052 hsv//eng
653 a basic (laboratory) research
653 a science
653 a clinical research
653 a practice
653 a diabetes
653 a type 1
653 a islet transplantation
700a Rickels, Michael R.u Univ Penn, Div Endocrinol Diabet & Metab, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA.4 aut
700a Eggerman, Thomas L.u NIDDK, NIH, Bethesda, MD 20892 USA.4 aut
700a Bridges, Nancy D.u NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.4 aut
700a Lafontant, David E.u Univ Iowa, Clin Trials Stat & Data Management Ctr, Iowa City, IA USA.4 aut
700a Qidwai, Julieu Univ Iowa, Clin Trials Stat & Data Management Ctr, Iowa City, IA USA.4 aut
700a Foster, Ericu Ferring Pharmaceut, Parsippany, NJ USA.4 aut
700a Clarke, William R.u Univ Iowa, Clin Trials Stat & Data Management Ctr, Iowa City, IA USA.4 aut
700a Kamoun, Maleku Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.4 aut
700a Alejandro, Rodolfou Univ Miami, Miller Sch Med, Diabet Res Inst, Miami, FL 33136 USA.;Univ Miami, Miller Sch Med, Clin Cell Transplant Program, Miami, FL 33136 USA.4 aut
700a Bellin, Melena D.u Univ Minnesota, Dept Endocrinol, Minneapolis, MN USA.4 aut
700a Chaloner, Kathrynu Univ Iowa, Clin Trials Stat & Data Management Ctr, Iowa City, IA USA.4 aut
700a Czarniecki, Christine W.u NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.4 aut
700a Goldstein, Julia S.u NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.4 aut
700a Hering, Bernhard J.u Univ Minnesota, Schulze Diabet Inst, Minneapolis, MN USA.;Univ Minnesota, Dept Surg, Box 242 UMHC, Minneapolis, MN 55455 USA.4 aut
700a Hunsicker, Lawrence G.u Univ Iowa, Clin Trials Stat & Data Management Ctr, Iowa City, IA USA.4 aut
700a Kaufman, Dixon B.u Univ Wisconsin, Dept Surg, Div Transplantat, Madison, WI USA.4 aut
700a Korsgren, Olleu Uppsala universitet,Klinisk immunologi4 aut0 (Swepub:uu)ollekors
700a Larsen, Christian P.u Emory Univ, Emory Transplant Ctr, Atlanta, GA 30322 USA.4 aut
700a Luo, Xunrongu Duke Univ, Dept Med, Durham, NC USA.4 aut
700a Naji, Aliu Univ Penn, Perelman Sch Med, Dept Surg, Div Transplantat, Philadelphia, PA 19104 USA.4 aut
700a Oberholzer, Joseu Univ Illinois, Dept Surg, Chicago, IL 60680 USA.4 aut
700a Posselt, Andrew M.u Univ Calif San Francisco, Dept Surg, San Francisco, CA USA.4 aut
700a Ricordi, Camillou Univ Miami, Miller Sch Med, Diabet Res Inst, Miami, FL 33136 USA.;Univ Miami, Miller Sch Med, Clin Cell Transplant Program, Miami, FL 33136 USA.4 aut
700a Senior, Peter A.u Univ Alberta, Clin Islet Transplant Program, Edmonton, AB, Canada.;Univ Alberta, Fac Med & Dent, Edmonton, AB, Canada.4 aut
700a Shapiro, A. M. Jamesu Univ Alberta, Clin Islet Transplant Program, Edmonton, AB, Canada.;Univ Alberta, Fac Med & Dent, Edmonton, AB, Canada.4 aut
700a Stock, Peter G.u Univ Calif San Francisco, Dept Surg, San Francisco, CA USA.4 aut
700a Turgeon, Nicole A.u Univ Texas Med Sch, Dept Surg, Austin, TX USA.4 aut
710a Harvard Med Sch, Div Transplant Surg, Massachusetts Gen Hosp, Boston, MA 02115 USA.b Univ Penn, Div Endocrinol Diabet & Metab, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA.4 org
773t American Journal of Transplantationd : John Wiley & Sonsg 21:4, s. 1477-1492q 21:4<1477-1492x 1600-6135x 1600-6143
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-450607
8564 8u https://doi.org/10.1111/ajt.16174

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy